Aurobindo Pharma Q2 net rises 4% to ₹848 crore
Formulations accounted for ₹7,325 crore of revenue, up from ₹6,640 crore a year earlier — a 10.3% year‑on‑year increase. That rise reflects a stronger contribution from finished pharmaceutical products within the company’s revenue mix. Key takeaways Formulations revenue grew to ₹7,325 crore, marking a 10.3% YoY increase. The jump from ₹6,640 crore suggests improving demand … Read more